NVO241129C113000
- 0.05
- -0.03-37.50%
Novo-Nordisk A/S Newsroom
Aurisco Pharmaceutical (605116.SH): Currently, there is no collaboration with Novo-Nordisk A/S.
On November 28, Glonghui reported that aurisco pharmaceutical (605116.SH) stated on the investor interaction platform that the company is actively developing the market for the active pharmaceutical ingredient semaglutide, and currently has no collaboration with novo-nordisk a/s.
Sector Update: Health Care Stocks Advance Wednesday Afternoon
LLY, NVO Stock Up as Biden Proposes Medicare Cover for Obesity Drugs
Novo Nordisk, KKR Joint Acquisition of Sylvan Gets EU Greenlight
Express News | Novo Nordisk Says Health Canada Approves Wegovy (Semaglutide Injection) To Reduce Risk Of Non-Fatal Myocardial Infarction
Will weight loss drugs be included in the US medical insurance, becoming the strongest "roadblock" for the Trump team?
The "Dual Weight Loss Champions" led the significant rise.
Health Care Up as Ely Lilly Rallies on Medicare Proposal -- Health Care Roundup
U.S. stocks closed: The Dow and S&P reached all-time highs, while general motors plunged nearly 9%.
① Most technology giants rose, only Tesla fell; ② Eli Lilly and Co rose by 4.5%, as Biden proposed health insurance coverage for weight loss drugs; ③ The Chinese concept stock Jinlong Index fell by 0.8%, Nio fell by 7.7%; ④ Apple proposed to increase investment by 0.1 billion US dollars to seek to lift the sales ban, but was rejected by the Indonesian government.
Novo and Lilly Surge as Amgen Stumbles in Competitive Weight-Loss Market
European Equities Close Lower in Tuesday Trading
The Biden administration has proposed covering weight loss medications under Medicare, while Trump's team may become the biggest obstacle.
①The Biden administration has proposed expanding the coverage of federal medical care and medical subsidies to include weight loss drugs; ②The White House claims that these drugs can prevent type 2 diabetes, lower the risk of cardiovascular diseases such as heart disease, but currently they are too expensive for Americans. ③This proposal may be blocked by the Trump administration taking office next year, as Senator Kennedy opposes weight loss drugs.
Novo Nordisk Says White House Obesity Plan Is Step in Right Direction -- Interview
European Equities Traded in the US as American Depositary Decline in Tuesday Trading
Express News | Benzinga Market Summary: Best Buy And Kohl's Cut Outlook, Biden Admin Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs, PResident-Elect Trump Threatens Tariffs On China, Canada And Mexico
Sector Update: Health Care Stocks Mixed Premarket Tuesday
Amgen (AMGN.US) released mid-term data on the weight loss therapy MariTide, showing weight loss effects comparable to Novo Nordisk.
Amgen announced on Tuesday that its experimental weight loss therapy MariTide achieved significant results in Phase 2 trials.
Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know
Weight-loss Drugmakers' Stocks Get a Boost From New Biden Proposal on Drug Coverage, but Will It Hold Up?
Today's Pre-Market Movers and Top Ratings | PSTX, LLY, KSS, BBY and More
Novo Nordisk and Eli Lilly Shares Are Trading Higher After the Biden-Harris Administration Proposed a New Step to Expand Coverage of Anti-obesity Medications for Medicare and Medicaid Beneficiaries.